Isolating High Telomerase Bone Marrow Stem Cells
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for isolating and expanding bone marrow mesenchymal stem cells (BMMSCs) are inefficient, as they fail to capture distinct subpopulations with enhanced therapeutic potential, particularly those with high telomerase activity, which are crucial for immune modulation and tissue regeneration.
Innovation Solution
The development of a method to isolate and expand BMMSCs with high telomerase activity, including non-adherent tBMMSCs, CD34+ BMMSCs, and telomerase-induced TAT-BMMSCs, using extracellular matrix-coated culture dishes and telomerase induction agents like aspirin, to enhance their immunomodulatory and regenerative capabilities.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional isolation methods are used for BMMSCs, then the isolation process is simple, but the therapeutic potential and telomerase activity are insufficient
Solution Approach 1:
The patent segments BMMSCs into distinct subpopulations based on adhesion properties (adherent vs. non-adherent) and surface markers (CD34+ vs. CD34-). This segmentation allows isolation of specific subpopulations with enhanced therapeutic potential, particularly non-adherent BMMSCs and CD34+ BMMSCs that exhibit higher telomerase activity and immunomodulatory capabilities.
Solution Approach 2:
The patent uses extracellular matrix (ECM) as an intermediary substance to differentiate between adherent and non-adherent BMMSCs. By coating culture dishes with ECM, the method enables selective adhesion of specific cell subpopulations, facilitating their isolation based on their differential adhesion properties without requiring complex separation devices.
2Productivity
If conventional culture methods are used for BMMSCs, then the culture process is simple, but the proliferation and differentiation capabilities are limited
Solution Approach 1:
The patent applies local quality by providing different culture conditions for different BMMSC subpopulations. Non-adherent BMMSCs and CD34+ BMMSCs are cultured under specific conditions that maintain their high telomerase activity and enhance their proliferation and differentiation capabilities, rather than using a uniform culture approach for all BMMSCs.
Solution Approach 2:
The patent utilizes parameter changes in telomerase activity as a key differentiator for identifying and culturing high-potential BMMSC subpopulations. By selecting cells with elevated telomerase activity and maintaining them under conditions that preserve this parameter, the method achieves enhanced proliferation and therapeutic efficacy.
3Reliability
If standard BMMSC isolation is used, then the process is efficient, but distinct subpopulations with high telomerase activity are not captured
Solution Approach 1:
The patent inverts the conventional adhesion-based isolation approach by specifically targeting and isolating non-adherent BMMSCs, which are typically discarded in standard methods. This inversion reveals a previously overlooked subpopulation with superior telomerase activity and therapeutic potential, turning a waste stream into a valuable resource.
Data Source
AI summary
Disclosed are isolated human bone marrow mesenchymal stem cells having high telomerase activity (tBMMSCs). Also disclosed are isolated human CD34+ bone marrow mesenchymal stem cells. Also disclosed are bone marrow mesenchymal stem cells treated with a telomerase induction agent.